LVP GP III, LLC 4
4 · Evoke Pharma Inc · Filed Aug 21, 2018
Insider Transaction Report
Form 4
Evoke Pharma IncEVOK
LVP GP III, LLC
10% Owner
Transactions
- Purchase
Common Stock
2018-08-20$2.35/sh+465,116$1,093,023→ 1,937,983 total(indirect: Directly owned by LVP III) - Purchase
Common Stock
2018-08-20$2.35/sh+11,628$27,326→ 48,449 total(indirect: Directly owned by Partners) - Purchase
Common Stock
2018-08-20$2.35/sh+23,256$54,652→ 96,897 total(indirect: Directly owned by Associates)
Holdings
- 5,250(indirect: Directly owned by LVPMC)
Common Stock
Footnotes (1)
- [F1]The reported securities are owned directly by each of LVPMC, LLC ("LVPMC"), LVP Life Science Ventures III, L.P. ("LVP III"), LVP III Associates, L.P. ("Associates") and LVP III Partners, L.P. ("Partners"). LVP GP III, LLC ("GP III") is the general partner of LVP III, Associates and Partners. GP III may be deemed to have sole voting power and dispositive power over the shares held by LVP III, Associates and Partners. Each of GP III and Patrick Latterell, the managing member of GP III and the manager of LVPMC, may be deemed to share voting and dispositive power over the reported securities and disclaim beneficial ownership of the reported securities held by LVPMC, LVP III, Associates and Partners except to the extent of any pecuniary interest therein.